Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 4911 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#4911, RRID:AB_2218913
- Product name
- Phospho-YAP (Ser127) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Storage
- -20°C
Submitted references Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP.
Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation.
Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development.
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
LATS2 is a tumor suppressor gene of malignant mesothelioma.
Hippo pathway effector Yap is an ovarian cancer oncogene.
Angus L, Moleirinho S, Herron L, Sinha A, Zhang X, Niestrata M, Dholakia K, Prystowsky MB, Harvey KF, Reynolds PA, Gunn-Moore FJ
Oncogene 2012 Jan 12;31(2):238-50
Oncogene 2012 Jan 12;31(2):238-50
Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
Donninger H, Allen N, Henson A, Pogue J, Williams A, Gordon L, Kassler S, Dunwell T, Latif F, Clark GJ
The Journal of biological chemistry 2011 May 27;286(21):18483-91
The Journal of biological chemistry 2011 May 27;286(21):18483-91
The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation.
Dong A, Gupta A, Pai RK, Tun M, Lowe AW
The Journal of biological chemistry 2011 May 20;286(20):18301-10
The Journal of biological chemistry 2011 May 20;286(20):18301-10
Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development.
Mao Y, Mulvaney J, Zakaria S, Yu T, Morgan KM, Allen S, Basson MA, Francis-West P, Irvine KD
Development (Cambridge, England) 2011 Mar;138(5):947-57
Development (Cambridge, England) 2011 Mar;138(5):947-57
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Kim NG, Koh E, Chen X, Gumbiner BM
Proceedings of the National Academy of Sciences of the United States of America 2011 Jul 19;108(29):11930-5
Proceedings of the National Academy of Sciences of the United States of America 2011 Jul 19;108(29):11930-5
LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, Toyokuni S, Osada H, Sekido Y
Cancer research 2011 Feb 1;71(3):873-83
Cancer research 2011 Feb 1;71(3):873-83
Hippo pathway effector Yap is an ovarian cancer oncogene.
Hall CA, Wang R, Miao J, Oliva E, Shen X, Wheeler T, Hilsenbeck SG, Orsulic S, Goode S
Cancer research 2010 Nov 1;70(21):8517-25
Cancer research 2010 Nov 1;70(21):8517-25
No comments: Submit comment
No validations: Submit validation data